title: Missed opportunities for Hepatitis B vaccination among diabetic patients.
abstract: Many infectious diseases in adults can be prevented by a 'life-long vaccination strategy'. Hepatitis B disease burden was shown to be higher in diabetic patients. American Advisory Committee on Immunization Practices recommends to vaccinate diabetic patients against hepatitis B since 2011. In this study, we aimed to determine hepatitis B virus serology status to determine the rates of diabetic patients who have indications for hepatitis B vaccination. The electronic database of the hospital was searched to identify adult patients aged above 18 years and with hemoglobin A1C levels of 6.5% or above, who have been seen at General Medicine Outpatient Clinics of a university hospital during a 3-year period. A total of 5187 patients were included in the study. After exclusion of patients with an incomplete serological panel, 1358 patients were included for further analyses. Twenty-nine percent of the patients had indication for hepatitis B vaccination, whereas only 8% were vaccinated. This study showed that nearly one third of patients who had hepatitis B serological data had an indication for hepatitis B vaccination and this is a clear reflection of the need to keep a lifelong vaccination log and inquire vaccination data.
authors.affiliation: a Department of Internal Medicine ; Hacettepe University Faculty of Medicine , Ankara , Turkey.
authors.forename: Lale
authors.initials: L
authors.lastname: Ozisik
authors.affiliation: a Department of Internal Medicine ; Hacettepe University Faculty of Medicine , Ankara , Turkey.
authors.forename: Mine Durusu
authors.initials: MD
authors.lastname: Tanriover
authors.affiliation: a Department of Internal Medicine ; Hacettepe University Faculty of Medicine , Ankara , Turkey.
authors.forename: Nursel
authors.initials: N
authors.lastname: Calik Basaran
authors.affiliation: a Department of Internal Medicine ; Hacettepe University Faculty of Medicine , Ankara , Turkey.
authors.forename: S Gul
authors.initials: SG
authors.lastname: Oz
authors.affiliation: b Department of Infectious Diseases and Clinical Microbiology ; Hacettepe University Faculty of Medicine , Ankara , Turkey.
authors.forename: Serhat
authors.initials: S
authors.lastname: Unal
mesh_terms: D000328:Adult; D048909:Diabetes Complications / Q000821:virology; D003920:Diabetes Mellitus; D005260:Female; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000097:blood / Q000276:immunology; D006512:Hepatitis B Core Antigens / Q000097:blood / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016036:Seroepidemiologic Studies; D014611:Vaccination; D055815:Young Adult
chemical_list: D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines
keywords: diabetes; hepatitis B; hepatitis B vaccine; seroprevalance; vaccination